Well, along with Steve, and a bunch of other people with lots to lose, I’m not going quietly.
I’m more than ready to pull the Big Yellow Handle on the “hot lots” issue.
These vaccine vials do NOT contain the same material, time after time, as they MUST, if the product is being manufactured under GMP conditions.
That’s implicit even in EU…
Well, along with Steve, and a bunch of other people with lots to lose, I’m not going quietly.
I’m more than ready to pull the Big Yellow Handle on the “hot lots” issue.
These vaccine vials do NOT contain the same material, time after time, as they MUST, if the product is being manufactured under GMP conditions.
That’s implicit even in EUAs, granted by FDA.
So either FDA has granted the manufacturers carte Blanche to ship anything they like, in which case the public needs to know that, or the companies are in breach of the EUA conditions. In which case the public needs to know that.
Those accepting vaccination presumably are doing so on the understanding that good quality, consistent manufacturing is taking place & they’re getting the same material as used in the clinical trials.
This simply isn’t true.
We don’t know what they’re getting.
As an industry veteran, I find that truly terrifying.
Whatever happened to the Pfizer requirement that the vaccibes needed to be kept at extremely low temperatures? As far as I know that has not been happening.
They stopped doing that. My guess is that they came up with that extreme requirement to keep initial distribution in protected channels. They were trying to prevent our side from analyzing the vials early on.
Dr Yeadon, do you believe the hot lots issue is by design, as an experiment or to predominantly poison ideologically opposed areas, or do you believe it's just sloppy manufacturing? If intentional, it seems impossible to track who gets how many of what type of vial. Thanks for all your work.
I think it’s deliberate, because they’re too good at manufacturing for the variation observed, which is systematic, to possibly be Chance.
You see, the differences in “performance” (toxicity) are real.
They’re not subtle differences.
That requires huge changes in the product. The allowed variation is very small, lot to lot.
General rule of thumb: differences in performance should be due to differences in the response of different people to a near identical product. That’s the intent behind the rules of GMP manufacturing.
Consistency & huge volumes, even of complex products, is what they’re incredibly good at.
So these big differences? Not chance, not luck, not within the GMP rules.
The clinical trials were not exactly in Pfizer’s favour, including one paralysed in the 12-15 cohort, now if you’re suggesting the vials distributed are even more nefarious…
Well, along with Steve, and a bunch of other people with lots to lose, I’m not going quietly.
I’m more than ready to pull the Big Yellow Handle on the “hot lots” issue.
These vaccine vials do NOT contain the same material, time after time, as they MUST, if the product is being manufactured under GMP conditions.
That’s implicit even in EUAs, granted by FDA.
So either FDA has granted the manufacturers carte Blanche to ship anything they like, in which case the public needs to know that, or the companies are in breach of the EUA conditions. In which case the public needs to know that.
Those accepting vaccination presumably are doing so on the understanding that good quality, consistent manufacturing is taking place & they’re getting the same material as used in the clinical trials.
This simply isn’t true.
We don’t know what they’re getting.
As an industry veteran, I find that truly terrifying.
Best wishes
Mike
EVERYTHING is changing with these vaccines:
- different formulations/versions
- freezing/refrigeration requirements
- abritrary shelf life extensions
- number of doses needed
- recommended time between doses
- match or mix doses
It’s monstrous, isn’t it?
Any one of those changes would, ib the saner era, have required EVIDENCE.
I despair at the near randomness of the posology, WITHOUT any evidence it’s safe & works.
When I gently challenge friends in the health service, I’m jumped on: “I think they know what they’re doing, Michael!”.
Oh, they know what they’re doing, alright!
Whatever happened to the Pfizer requirement that the vaccibes needed to be kept at extremely low temperatures? As far as I know that has not been happening.
They stopped doing that. My guess is that they came up with that extreme requirement to keep initial distribution in protected channels. They were trying to prevent our side from analyzing the vials early on.
https://nypost.com/2021/02/19/pfizer-covid-vaccine-doesnt-need-to-be-stored-at-freezing-temps-anymore/
Have you seen this:
http://enformtk.u-aizu.ac.jp/howard/gcep_dr_vanessa_schmidt_krueger/
Dr Yeadon, do you believe the hot lots issue is by design, as an experiment or to predominantly poison ideologically opposed areas, or do you believe it's just sloppy manufacturing? If intentional, it seems impossible to track who gets how many of what type of vial. Thanks for all your work.
I think it’s deliberate, because they’re too good at manufacturing for the variation observed, which is systematic, to possibly be Chance.
You see, the differences in “performance” (toxicity) are real.
They’re not subtle differences.
That requires huge changes in the product. The allowed variation is very small, lot to lot.
General rule of thumb: differences in performance should be due to differences in the response of different people to a near identical product. That’s the intent behind the rules of GMP manufacturing.
Consistency & huge volumes, even of complex products, is what they’re incredibly good at.
So these big differences? Not chance, not luck, not within the GMP rules.
It’s been a year. They know about it.
They’re not correcting it.
It’s deliberate.
The clinical trials were not exactly in Pfizer’s favour, including one paralysed in the 12-15 cohort, now if you’re suggesting the vials distributed are even more nefarious…
I’m not suggesting anything. Look at the VAERS data. That’s what it shows. Huge 1000X variability in adverse effects per lot from low to high.
Are you suggesting the boys got shot from a bad lot?
See my reply to Max. Reporting isn’t suggesting. You can verify for yourself.
We need the regulator & manufacturers to explain the us how this occurs. It is occurring. No question.
Please contact me at spiritwarrior76@protonmail.com. Thanks. K